GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Other Stockholders Equity

Destiny Pharma (LSE:DEST) Other Stockholders Equity : £-0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma Other Stockholders Equity?

Destiny Pharma's Other Stockholders Equity for the quarter that ended in Dec. 2023 was £-0.00 Mil.

Destiny Pharma's quarterly Other Stockholders Equity declined from Dec. 2022 (£0.00 Mil) to Jun. 2023 (£-0.00 Mil) but then stayed the same from Jun. 2023 (£-0.00 Mil) to Dec. 2023 (£-0.00 Mil).

Destiny Pharma's annual Other Stockholders Equity increased from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.00 Mil) but then declined from Dec. 2022 (£0.00 Mil) to Dec. 2023 (£-0.00 Mil).

Destiny Pharma Other Stockholders Equity Historical Data

The historical data trend for Destiny Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma Other Stockholders Equity Chart

Destiny Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Destiny Pharma Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Destiny Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Destiny Pharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Destiny Pharma (LSE:DEST) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Other Stockholders Equity
Comparable Companies
LSE:SBTX LSE:SAR LSE:TRX LSE:C4XD LSE:AREC LSE:ETX LSE:POLB LSE:4BB LSE:OPTI LSE:OBD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
D89:Germany
Address
Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB
Website
https://www.destinypharma.com
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines